| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |